Skip to main content
. 2016 Jun 8;6:27396. doi: 10.1038/srep27396

Figure 8. Proteomics analyses of compound 2-treated MCF-7 cells.

Figure 8

(A) Proteomics-based identification of novel ERK1 or MEK1 apoptotic pathways in compound 2-treated MCF-7 cells. (B) The difference of protein levels (upregulation or downregulation) between control and compound 2-treated MCF-7 cells. (C) The apoptosis-related enrichment analyses of compound 2-treated MCF-7 cells.